These findings verified our hypothesis that intrathecal injection of hUMSCs overexpressing HO-1 can promote functional outcomes in cystitis rats through reducing neuroinflammation, and the TLR4/p65/NLRP3 pathway may be the potential regulatory target. This evidence concerns the gene NLRP3 and chronic cystitis.